Login / Signup
Charles F Murchison
ORCID
Publication Activity (10 Years)
Years Active: 2023-2024
Publications (10 Years): 5
Top Topics
Study Protocol
Randomized Controlled Trial
Open Label
Chronic Rhinosinusitis
Top Venues
Epilepsia
medRxiv : the preprint server for health sciences
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Nathan B Fountain
,
Mark Quigg
,
Charles F Murchison
,
Enrique Carrazana
,
Adrian L Rabinowicz
Analysis of seizure-cluster circadian periodicity from a long-term, open-label safety study of diazepam nasal spray.
Epilepsia
65 (4) (2024)
Nathan B Fountain
,
Mark Quigg
,
Charles F Murchison
,
Enrique Carrazana
,
Adrian L Rabinowicz
Analysis of seizure-cluster circadian periodicity from a long-term, open-label safety study of diazepam nasal spray.
Epilepsia
65 (4) (2024)
Nathan B Fountain
,
Mark Quigg
,
Charles F Murchison
,
Enrique Carrazana
,
Adrian L Rabinowicz
Analysis of seizure-cluster circadian periodicity from a long-term, open-label safety study of diazepam nasal spray.
Epilepsia
65 (4) (2024)
Nathan B Fountain
,
Mark Quigg
,
Charles F Murchison
,
Enrique Carrazana
,
Adrian L Rabinowicz
Analysis of seizure-cluster circadian periodicity from a long-term, open-label safety study of diazepam nasal spray.
Epilepsia
(2024)
Haydeh Payami
,
Gwendolyn Cohen
,
Charles F Murchison
,
Timothy Robert Sampson
,
David G Standaert
,
Zachary D Wallen
Population fraction of Parkinson's disease attributable to preventable risk factors.
medRxiv : the preprint server for health sciences
(2023)